|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2001-1-17
|
|
pubmed:abstractText |
Haemangioblastoma within CNS occurs either as a sporadic tumor or as a syndrome referred to as Morbus Hippel-Lindau (MHL). Since 1993 it has been known that this disease is caused by MHL mutation of the suppressor gene on the chromosome 3p25-p26. The syndrome can include malign tumors of abdominal organs.
|
|
pubmed:language |
cze
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0006-9248
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
101
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
503-6
|
|
pubmed:dateRevised |
2009-11-11
|
|
pubmed:meshHeading |
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
[Central nervous system hemangioblastoma: its role in von Hippel-Lindau disease].
|
|
pubmed:affiliation |
Department of Neurosurgery, Masaryk University and University Hospital, Brno. bll@fmed.uniba.sk
|
|
pubmed:publicationType |
Journal Article,
English Abstract
|
